RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 148 filers reported holding RELAY THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,668,054 | -33.0% | 673,966 | 0.0% | 0.15% | -24.4% |
| Q2 2023 | $8,465,013 | -23.7% | 673,966 | 0.0% | 0.20% | -24.2% |
| Q1 2023 | $11,100,220 | +10.2% | 673,966 | 0.0% | 0.26% | +9.5% |
| Q4 2022 | $10,069,052 | -27.2% | 673,966 | +9.0% | 0.24% | -32.2% |
| Q3 2022 | $13,831,000 | +33.6% | 618,267 | 0.0% | 0.36% | +18.6% |
| Q2 2022 | $10,356,000 | -42.5% | 618,267 | +2.8% | 0.30% | -33.6% |
| Q1 2022 | $18,008,000 | -1.9% | 601,667 | +0.7% | 0.45% | +6.8% |
| Q4 2021 | $18,357,000 | +24.0% | 597,767 | +27.3% | 0.42% | +36.3% |
| Q3 2021 | $14,805,000 | -10.1% | 469,560 | +4.3% | 0.31% | -4.6% |
| Q2 2021 | $16,475,000 | +89.0% | 450,258 | +78.6% | 0.33% | +71.6% |
| Q1 2021 | $8,716,000 | -49.1% | 252,127 | -38.8% | 0.19% | -47.7% |
| Q4 2020 | $17,123,000 | -2.8% | 412,000 | -0.4% | 0.36% | -18.8% |
| Q3 2020 | $17,618,000 | – | 413,674 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 183,112 | $5,665,000 | 3.48% |
| Casdin Capital, LLC | 3,668,574 | $115,670,000 | 2.88% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $879,843,000 | 2.73% |
| BVF INC/IL | 2,049,113 | $64,609,000 | 2.52% |
| Fernwood Investment Management, LLC | 185,063 | $5,835,000 | 2.00% |
| EcoR1 Capital, LLC | 1,385,276 | $43,678,000 | 1.52% |
| Boxer Capital, LLC | 1,294,132 | $40,804,000 | 1.42% |
| Integral Health Asset Management, LLC | 140,000 | $4,414,000 | 1.27% |
| Alphabet Inc. | 1,641,497 | $51,756,000 | 1.23% |
| Bellevue Group AG | 3,755,962 | $118,426,000 | 1.20% |